For instance, genes that lose directionality at high MYC levels were expressed at reduced levels in MYC-driven group 3 medulloblastoma and aggressive neuroblastoma compared to less aggressive sub-entities (Figure 7H). The gene discussed is MYC; the disease is medulloblastoma.